-
1
-
-
0030907535
-
Antibodies to recombinant human erythropoietin causing red cell aplasia
-
Prabhaker SS, and DMuhlfelder T: Antibodies to recombinant human erythropoietin causing red cell aplasia. Clinical Nephrology 47: 331-5, 1997
-
(1997)
Clinical Nephrology
, vol.47
, pp. 331-335
-
-
Prabhaker, S.S.1
Dmuhlfelder, T.2
-
2
-
-
0030573330
-
Brief Report: Auto antibodies against erythropoietin in a patient with pure red cell aplasia
-
Casadevall N, Dupey E Motho-Sebatier, Tobelass G, Varet B, Mayeux P: Brief Report: Auto antibodies against erythropoietin in a patient with pure red cell aplasia. N Eng J Med 334: 630-634, 1996
-
(1996)
N Eng J Med
, vol.334
, pp. 630-634
-
-
Casadevall, N.1
Dupey E Motho-Sebatier2
Tobelass, G.3
Varet, B.4
Mayeux, P.5
-
3
-
-
0942287103
-
Anti-erythropoietin antibodies and pure red cell aplasia
-
Rossert J, Casadevall N, Eckardt K-U. Anti-erythropoietin antibodies and pure red cell aplasia. J Am Soc Nephrol 15: 398-406, 2004
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 398-406
-
-
Rossert, J.1
Casadevall, N.2
Eckardt, K.-U.3
-
4
-
-
0036707892
-
Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoteins
-
Weber G, Gross J, Kromminga A, Loew H-H, Eckardt K-U. Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoteins. J Am Soc Nephrol 13: 2381-3, 2002
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 2381-2383
-
-
Weber, G.1
Gross, J.2
Kromminga, A.3
Loew, H.-H.4
Eckardt, K.-U.5
-
5
-
-
0037374192
-
Cyclosporine treatment for patients with CRF who developed pure red blood cell aplasia following EPO therapy
-
Chng WJ, Tan LK, Liu TC. Cyclosporine treatment for patients with CRF who developed pure red blood cell aplasia following EPO therapy. Am J Kidney Dis 41: 692-5, 2003
-
(2003)
Am J Kidney Dis
, vol.41
, pp. 692-695
-
-
Chng, W.J.1
Tan, L.K.2
Liu, T.C.3
-
6
-
-
0942306191
-
Treatment of antibody-mediated pure red cell aplasia
-
Verhelst D, Rossert J, Casadevall N, MacDougall IC, Kruger A, Eckardt KU: Treatment of antibody-mediated pure red cell aplasia. J Am Soc Nephrol 14: 27A, 2003
-
(2003)
J Am Soc Nephrol
, vol.14
-
-
Verhelst, D.1
Rossert, J.2
Casadevall, N.3
MacDougall, I.C.4
Kruger, A.5
Eckardt, K.U.6
-
7
-
-
0037075272
-
Pure red cell aplasia and anti erythropoietin antibodies in patients treated with recombinant erythropoietin
-
Casadevall N, Natf J, Mayeux P et al: Pure Red Cell Aplasia and Anti erythropoietin Antibodies in patients treated with Recombinant Erythropoietin. N Eng J Med 346: 469-75, 2002
-
(2002)
N Eng J Med
, vol.346
, pp. 469-475
-
-
Casadevall, N.1
Natf, J.2
Mayeux, P.3
-
8
-
-
0036598634
-
Bioequivalence and the immunogenicity of biopharmaceuticals
-
Schellekens H: Bioequivalence and the immunogenicity of biopharmaceuticals. Nat Rev Drug Discov 1: 457-462, 2002
-
(2002)
Nat Rev Drug Discov
, vol.1
, pp. 457-462
-
-
Schellekens, H.1
-
9
-
-
0035895071
-
Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin
-
Skibeli V, Nissen-Lie G, Torjesen P: Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin. Blood 98: 3626-3634, 2001
-
(2001)
Blood
, vol.98
, pp. 3626-3634
-
-
Skibeli, V.1
Nissen-Lie, G.2
Torjesen, P.3
|